We recently described a new class of long noncoding RNAs (lncRNAs) that are distinguished by especially tight chromatin association and whose presence is strongly correlated to expression of nearby genes. Here, we examine the cis-enhancer mechanism of this class of chromatin-enriched RNA (cheRNA) across multiple human cell lines. cheRNAs are largely cell type specific and provide the most reliable chromatin signature to predict cis-gene transcription in every human cell type examined. Targeted depletion of three cheRNAs decreases expression of their neighboring genes, indicating potential co-activator function, and single-molecule fluorescence in situ hybridization (smFISH) of one cheRNA-distal target gene pair suggests a spatial overlap consistent with a role in chromosome looping. Additionally, the cheRNA HIDALGO stimulates the fetal hemoglobin subunit gamma 1 (HBG1) gene during erythroid differentiation by promoting contacts to a downstream enhancer. Our results suggest that multiple cheRNAs activate proximal lineage-specific gene transcription.
a r t i c l e s
Noncoding RNAs are thought to promote transcription initiation of coding genes by recruiting histone-modifying complexes [1] [2] [3] [4] , stabilizing transcription factor or mediator binding 2, [5] [6] [7] , and increasing the strength of promoter-enhancer looping 2, 5, [8] [9] [10] . In light of the recently appreciated promiscuity of lncRNA-protein interfaces 11 , how lncRNA interactions can achieve their implicated roles with such limited specificity has become a central question. One possible resolution could be spatially restricted activity due to immobilization of certain lncRNA at the sites of their production, as has been observed in a limited number of cases 5, [8] [9] [10] 12, 13 . A more widespread role for this type of mechanism was suggested by our identification of cheRNAs, a new class of several thousand lncRNAs in HEK293 cells defined by high chromatin enrichment as a consequence of their ongoing transcription 14 . Although cheRNAs are molecularly distinct from canonical enhancer RNAs (eRNAs), they exhibit a strong correlation to proximal gene expression. Further support for the idea that biochemical fractionation of chromatin is a powerful approach to identify RNA molecules that act locally was provided by the demonstration that some eRNAs that activate nearby genes in response to epidermal growth factor are also enriched in the chromatin fraction 10 . However, many important questions regarding cheRNAs and their relationship to nearby genes remain. How general are their properties and functions? To what extent are they shared between different cell lineages? Do cheRNA molecules promote neighboring gene transcription, or are they inert byproducts of enhancer transcriptional activity (both cases have been observed for other noncoding RNA (ncRNA) classes 5, [8] [9] [10] [15] [16] [17] [18] )? Finally, how might these regulatory modules have evolved?
To begin to address these questions, we examined cheRNAs in other cell types and explored the functional consequences of their perturbation. Quantitative chromatin enrichment of nuclear RNA from three distinct cell types shows that the vast majority of cheRNAs are cell type specific. Nevertheless, proximity to a cheRNA is a more effective predictor of cis-gene expression than are putative enhancers derived from chromatin mark signatures, previously annotated lncRNAs or eRNAs. Our prior work established that most cheRNAs remain attached to chromatin via RNAP II 14 . We now directly measure the spatial distribution of one cheRNA relative to its site of transcription and the putative target gene and find them to be remarkably colocalized despite a >50-kb spacing along the chromosomal coordinate. Targeted depletion of several candidate cheRNAs produces significant decreases in neighboring gene expression for 75% of the loci examined, establishing cheRNAs as transcriptional activators. Characterizing a more specific example, we find that the cheRNA molecule HIDALGO is required for full stimulation of hemoglobin subunit HBG1 during erythroid differentiation, and that knockdown of HIDALGO reduces contact between the HBG1 promoter and a downstream enhancer. Finally, virtually all cheRNAs reside within class I transposable elements, providing a plausible evolutionary path for this form of regulation.
RESULTS

Chromatin-enriched ncRNAs are lineage specific and correlate with proximal gene transcription
To characterize chromatin-enriched RNAs in multiple human cell lines, we performed biochemical fractionation of nuclei, coupled to calibrated RNA-seq 14, 19, 20 from H1 human embryonic stem cells (H1 hESCs) and myeloid leukemia cells (K562), which are the most divergent tier 1 ENCODE cell types 21 . Subnuclear-compartment quantification of de novo-assembled transcripts ( Supplementary  Fig. 1a-c) identified 3,293 and 1,136 cheRNAs in K562 cells and H1 hESCs, respectively (Fig. 1a, Supplementary Fig. 2a ,b, and bioinformatics section in Supplementary Note 1). This extension of our prior HEK293 results 14 demonstrates the generality of cheRNAs across diverse cell lineages and provides a resource for future exploration of lncRNA mechanisms operating at the chromatin interface (Source Data for Fig. 1 ). Previously annotated lncRNAs and eRNAs also exhibit modest chromatin enrichment, consistent with many of their associated functions 1,2,5-10,22 , although they are on average less enriched than cheRNAs (Fig. 1b) .
Calibrated RNA-seq also provides a rough measure of the RNA copy number and distribution between subnuclear compartments. We measured 120 ± 40 copies of XIST RNA in chromatin, as compared to 2.5 ± 0.4 copies in the soluble nuclear extract per human K562 cell, congruent with previous estimates of murine Xist (~50-200 copies per cell) 23 . Given the likelihood of incomplete recovery during nuclear fractionation we estimate that most cheRNAs are present at ~1-10 copies per cell (Fig. 1c) , consistent with smFISH measurements for other lncRNA in a variety of cell types 1, 24 .
Comparison of cheRNA species from our previous HEK293 data set with those from K562 and H1 hESCs reveals that the majority of cheRNAs display cell-type-specific expression (Fig. 1d) , are largely distinct from other annotated ncRNA species in each cell type, and display little coding potential (Supplementary Fig. 2a,b) . This strongly restricted expression is in contrast to activating RNAs (ncRNA-a), an annotation of cis-activating lncRNAs that were largely shared between three disparate cell types 25 .
Analogous to observations in HEK293 cells 14 , the presence of a proximal cheRNA in K562 and H1 hESCs is highly correlated to nearby gene expression, and substantially more coupled to cis-gene a r t i c l e s a r t i c l e s expression than neighboring enhancers annotated by chromatin signatures [26] [27] [28] or transcriptionally active eRNA loci 29 ( Fig. 1e,  Supplementary Fig. 2c ). This correlation is even more pronounced for cheRNAs that are downstream of and in the same sense as their coding neighbor. In some cases, biogenesis of cheRNAs may be linked to their upstream coding gene 30 or distinct, as defined by a 5′ cap (Supplementary Fig. 2d ) and canonical promoter-chromatin hallmarks 14 . cheRNA-proximal coding genes also appear to be specifically expressed in their respective cell types, including genes in the ERK1/2 cascade in H1 hESCs 31 and JAK-STAT signaling in K562 (ref. 32) (Supplementary Fig. 2e ), hinting that cheRNAs may have a role in cell-type-specific gene expression rather than basal function.
To investigate where cheRNAs reside in the 3D genomic architecture, we analyzed cheRNA positions relative to annotated topologically associating domains (TADs) in K562 cells 33 . cheRNA density displays local peaks at TAD boundaries (Fig. 1f) , congruent with a recent model suggesting that ncRNA transcription can serve as focal points for chromosome domain contacts 17 . Furthermore, the cheRNA correlation to proximal-gene expression applies to all genes within a given TAD (Supplementary Fig. 2c ).
smRNA-FISH indicates that a cheRNA acts near its site of production Although the bulk of cheRNA are tightly associated with chromatin through the act of ongoing or stalled RNAPII transcription 14 , our prior measurements did not provide spatial information about the site of attachment. We sought to quantify the physical proximity of a cheRNA molecule relative to its site of production and presumptive neighboring target gene by smFISH. The PVT1 gene, which in patient tumors frequently occurs in tandem with MYC amplification 34 , encodes a highly chromatin-enriched ncRNA in HEK293 and K562 cells, meriting cheRNA classification (Fig. 2a,c) . There are multiple enhancers of MYC transcription resident within PVT1 (e1-4) 35 ( Fig. 2c) . Curiously, the latter two enhancers reside in a region in PVT1 that is resistant to inhibition by the RNAPII elongation inhibitor DRB (Fig. 2b,c) .
We simultaneously targeted MYC introns and PVT1 exons with specific probes in two-color smFISH (Supplementary Table 1 ) to query the location of all PVT1 forms as compared to the nascent pool of MYC transcripts still resident at the MYC locus (Fig. 2d,e) 19 . We observe that PVT1 exon staining is largely resident in the nucleus, distributed into only a few discrete puncta per cell (mean = 1.6 ± 0.4, Fig. 2e) . Similarly, MYC intronic RNA, indicative of local transcription at the MYC locus, is largely restricted to approximately one nucleus-resident body per cell, and many cells did not display any focal staining. Analysis of nuclei that contain at least one of each color focus shows that PVT1 RNA is strikingly colocalized with ongoing transcription from the MYC gene (Fig. 2d,e) , predominantly overlapping within the optical diffraction limit for these dyes. Specifically, the median distance between the nearest PVT1 and MYC foci for a given nucleus, 199 nm, is far closer than the minimum spacing between the sites of RNA biogenesis in extended conformation (the distance range from a notional 30-nm to 10-nm fiber would be ~420-7,700 nm for 55 kb) 36 . Our results provide new and orthogonal single-cell evidence that the PVT1 enhancers are in close proximity to the MYC locus, consistent with physical contact observed by RNAPII ChIA-PET 37 , while arguing that the PVT1 cheRNA stays largely resident at the site of its production.
Function of cheRNA transcription on neighboring gene expression
The high correlation of active gene expression neighboring cheRNA loci, and other examples of ncRNA acting in cis 1, 2, 5, [8] [9] [10] 25 , prompted us to test whether cheRNAs promote local gene expression. We used CRISPRi 38 a r t i c l e s IL6. These pairs were chosen from the most highly expressed cheRNAs in K562 cells. Consistent with our metagene analysis (Fig. 1f) , each of these cheRNA-gene pairs fell on the edge of a chromosomecontact domain 33 , although they were not selected on this basis ( Supplementary Fig. 3d-f ). Several guide RNAs (sgRNAs) targeting each cheRNA (Supplementary Table 1 ) reduced cheRNA levels by 60-95%, leading to proportional reduction of expression of the most proximal gene in two of three cases (P < 0.05, Welch's two-tailed t test, Fig. 3 ). Despite effective targeting of PAINE, none of the sgRNAs produced substantial changes in PDCD6IP expression, revealing that not all cheRNAs act on their nearest-neighbor gene.
We conclude that the CRISPRi effects are on target, as distinct sgRNAs display similar perturbations, sgRNA targeting sites between B3GNT2 and its neighboring cheRNA BONIFACIO did not alter B3GNT2 expression, and no consistent perturbations were observed for the housekeeping gene GAPDH (Supplementary Fig. 3a) . Moreover, the same sgRNAs transfected in HEK293 CRISPRi cells, which modestly express PDCD6IP and B3GNT2 but not the corresponding cheRNAs, did not lead to knockdown of these genes ( Supplementary Fig. 3b,c) . Collectively, these data indicate that cheRNA loci can act as transcriptional activators in cis, although they do not distinguish whether an act of transcription or the cheRNA molecule itself is responsible for the effect. We subsequently explored this distinction in the context of a developmentally induced gene-cheRNA pair.
cheRNA HIDALGO couples an enhancer and promoter of HBG1 to activate HBG1 transcription To determine whether cheRNAs play a role in differentiation, we induced K562 cells toward the erythroid lineage by treatment with the small molecule hemin for 48 h 39 , and then performed nuclear fractionation and sequencing. In contrast to our cell-line comparisons, 75% of cheRNA were shared with uninduced K562 cells (Supplementary Fig. 4a ). Of the 172 upregulated coding genes, 27 were flanked by a cheRNA within 100 kb, a slight overrepresentation over chance expectation (P < 0.02, two-tailed Fisher's exact test).
To better understand cheRNA biogenesis and putative enhancer mechanisms in differentiation, we analyzed an erythroid cheRNA-gene pair. A hallmark of erythroid commitment is upregulation of the HBG1 and HBG2 chains of fetal hemoglobin (γ-globin), for which hemin induction of K562 cells is an effective model system 39 . We observed chromatin-enriched transcription extending 3.7 kb beyond or n = 4 (f) independent targeting transfections and n = 6 (d,e) or n = 7 (f) independent negative control sorted transfections (Online Methods). *P < 0.05, **P < 0.005, ***P < < 0.001 relative to negative control (Welch's two-tailed t test). a r t i c l e s HBG1 in both uninduced and induced states in a region previously shown to have enhancer activity in reporter assays 40, 41 (Fig. 4a) , whereas no transcription was observed at this locus in H1 hESC cells (Supplementary Fig. 4b ). ChIP-seq data 21 in this region reveals chromatin features characteristic of an unannotated promoter downstream of HBG1, with overlapping peaks for transcription factor binding sites, H3K4me3, H3K27ac, RNAP II, and DNase I hypersensitivity coupled to evidence of 5′-capped transcripts (Fig. 4b) . Intriguingly, transcription of this cheRNA, hereafter called HIDALGO for 'hemininduced cheRNA downstream of fetal hemoglobin' , is induced early in erythroid differentiation within 2-4 h after hemin addition, and then returns to basal levels within 2 d (Fig. 4c) . We examined HIDALGO RNA biogenesis by 5′ rapid amplification of cDNA ends (5′ RACE), which revealed a complex set of transcripts emanating from the TSS of HBG1 and a location downstream near our predicted HIDALGO TSS (Fig. 5a) . Whereas one transcript that originates from the HBG1 TSS represents readthrough that escapes polyadenylation (isoform #2), two others are out of frame and riddled with stop codons, seemingly due to errant or alternative splicing (Fig. 5a,  Supplementary Fig. 4c ). Owing to incomplete processing and chromatin tethering, all of these transcripts are de facto cheRNAs, and we refer to them as HIDALGO isoforms herein. To assess the proportion of HBG1 TSS transcripts that escape polyadenylation, we performed 3′ RACE on HBG1, which revealed that >83% of transcripts are processed at the normal polyadenylation site (PAS) to become mature mRNA (Supplementary Fig. 4d) . Readthrough from the HBG1 promoter, particularly isoforms #1 and 2, composes the majority (90-95%) of basal HIDALGO transcript levels ( Supplementary Fig. 4e,f) . Hemin induces all four RACE transcripts, although the transcript emanating from the cryptic TATA box (#4) represents the greatest fold change, comprising ~15% of HIDALGO RNA 2 h after induction (Supplementary Fig. 4e,f) .
We used CRISPRi to inhibit readthrough transcription from the HBG1 gene and initiation from the downstream TATA box (Fig. 5a) . Because the two fetal hemoglobin genes are only 3.5 kb apart on chromosome 11 and are >99% identical at the mature RNA level, HBG2 transcripts serve as an excellent control for HBG1-specific effects. To this end, we deployed primer sets that target unique intronic or 3′-UTR sequences to distinguish these RNA species ( Supplementary  Fig. 5b,f and Supplementary Fig. 6) . Each of the sgRNAs led to a decrease in transcription of HBG1, but not HBG2, proportional to the level of cheRNA knockdown (Fig. 5b,c and Supplementary  Fig. 4g ). As a control for the spatial distribution of dCas9-KRAB to the 3′ end of HBG1, we confirmed that a gene without a nearby cheRNA was not suppressed when using an sgRNA at the same relative location (Supplementary Fig. 5a ). Moreover, 3′ RACE of HBG1 demonstrates that the majority of transcripts are processed immediately following the PAS (Supplementary Fig. 4d ), so any effect on this pool is restricted to the fewer than 17% of transcripts that escape 3′ processing, and thus could not account for the observed 88% decrease in HBG1 (Fig. 5b,c) .
While our CRISPRi experiments demonstrate that the HIDALGO locus is an activator of HBG1, they do not distinguish whether the act of transcription through HIDALGO or the RNA molecule itself is functionally relevant 17, 18 . To test the latter mechanism, we used antisense oligonucleotides (ASOs) to specifically degrade complementary RNA through nuclear RNase H-initiated cleavage 42 . We observed decreases in HBG1 transcription commensurate to the degree of HIDALGO knockdown (P < 0.05, t test), demonstrating that the RNA molecule plays a functional cis-regulatory role (Fig. 5d) . Finally, inhibiting HIDALGO during hemin-induced erythroid differentiation prevents HBG1 induction (Fig. 5e) , suggesting a role for this cheRNA in developmental transcriptional plasticity.
As several lncRNAs and eRNAs facilitate contact between promoter and enhancer elements through chromatin looping 2,5,8-10 , we tested whether a similar model operates at the HIDALGO-HBG1 locus. Chromatin confirmation capture (3C) 43 demonstrates that the HBG1 promoter contacts HBG1 exon 2 and the HIDALGO #4 TSS, both of which are diminished by ASO (Fig. 6a) or CRISPRi depletion of HIDALGO (Supplementary Fig. 5c ). Although each of these perturbations acts through distinct mechanisms, as reflected by distinct changes in the histone modification patterns (Fig. 6b) , the consequences in regard to contact frequency are similar. CRISPRi targeting of promoters is thought to act by recruiting the Set1DB methyltransferase to install the H3K9me3 mark 44 . Remarkably, our ICeChIP quantification 45 demonstrates that H3K9me3 approaches saturation (100%) proximal to the site of dCAS9-KRAB-sgRNA3 binding near the TSS of HIDALGO #4, with concomitant slight increases at the HBG1 promoter. In contrast, antisense oligonucleotide targeting of the HIDALGO molecule does not substantially alter the pattern of H3K4me3 and H3K9me3 at the two sites queried. Yet there is a slight increase in H3K27me3 at the HBG1 promoter, perhaps indicating spreading of this mark 46 as a consequence of altered chromatin architecture. Crucially, the TSS of HIDALGO #4 near the 3C contact is a potent transcriptional activator in luciferase assays, consistent with a potential enhancer role modulated by the HIDALGO cheRNA and supported by prior reports of enhancer elements within this region 40, 41 (Fig. 6c) . Taken together, our results Fold change is calculated relative to a nontargeting negative control sgRNA (−) and to 18S RNA by RT-qPCR (n = 1 sorted transfection; meana r t i c l e s indicate that the HIDALGO RNA molecule confers cis activation of HBG1 by mediating contacts with a downstream enhancer element (Fig. 6d) to promote HBG1 induction during the early stages of erythroid differentiation.
DISCUSSION
CheRNAs are operationally defined by statistically significant enrichment in chromatin upon biochemical fraction of nuclei. Here, we find that cheRNAs are largely cell type specific and that their presence is more highly correlated with cis-gene expression than other metrics of enhancer annotation. In human cells, the majority of genes that cheRNAs abut are tissue restricted, suggesting potential roles in lineage differentiation or maintenance. Beyond this correlation, we have demonstrated a functional role of several cheRNAs in promoting proximal-gene expression.
Despite the modest overlap between cheRNA, eRNA and lncRNA transcripts (Supplementary Fig. 2a) , our approach may also capture the cis-acting subpopulations of the latter two classes of molecules. Several lines of evidence support the concept that cis-regulatory-element transcription mediates enhancer activity 5, 9, 10, 14, [47] [48] [49] [50] . Whether apparent ncRNA distinctions such as length or bidirectional transcription are functionally consequential remains a crucial question for the field. Given the strong correlation of ncRNA biochemically isolated from chromatin to cis-gene transcription 10, 14 and data presented herein, a classification based on chromatin enrichment may prove to be a more faithful metric of enhancer function and could be a powerful adjunct to the use of other chromatin signatures [26] [27] [28] in de novo enhancer prediction.
Chromatin looping from cheRNAs to tether enhancers to target promoters
The high correlation of gene activation with downstream sense cheRNAs suggests a model in which pioneering rounds of transcription that bypass normal termination could potentiate the transcription of a downstream enhancer. The cheRNA product could facilitate looping from the newly activated enhancer to the gene promoter (Fig. 6d) , setting up a feed-forward loop for stable expression analogous to the gene loops described in yeast 51 . Including prior experiments with PVT1 (ref. 35) , knockdown of three out of four cheRNAs in the downstream sense orientation using CRISPRi led to a decrease in expression of their upstream neighbors. However, activation of IL6 transcription by the upstream divergent ILYICH cheRNA indicates that this orientation is not an absolute requirement. Our more detailed analysis of the HBG1-HIDALGO locus supports the model of pioneering readthrough transcription of the coding gene to potentiate downstream enhancer transcription. The granular kinetics of transcriptional activation through the HBG1-HIDALGO locus upon erythroid differentiation, where both transcripts increase seemingly in lockstep, is consistent with this model. In particular, ASO depletion of the cheRNA HIDALGO, some of which represent readthrough transcripts from the upstream HBG1 promoter, led to a decrease of HBG1 transcripts far greater than can be accounted for by depletion of only the readthrough pool. By targeting the cheRNA for cleavage without altering its transcription or changing the underlying DNA sequence, we demonstrate that, at least in this scenario, the RNA molecule itself is also important in promoting cis-enhancer activity. Knockdown of HIDALGO by either ASO or CRISPRi led to decreased chromatin contacts between the enhancer at the TSS of one of the HIDALGO isoforms with the promoter of HBG1, supporting a role for the RNA in bridging these two elements to facilitate successive rounds of transcription.
Among mechanisms previously described in the literature, that involving, estrogen-inducible eRNA molecules tethered near distal enhancers that promote transcriptional activation of gene targets 9 is most similar to the HIDALGO-HBG1 mechanism. As with HIDALGO, changes in locus architecture occur in response to both small-molecule activation and ASO-mediated depletion of eRNA. Looping is an implied function of several lncRNA-coding-gene paradigms as well, a r t i c l e s but direct evidence of the transcript acting in cis has remained elusive. The class of molecules termed 'ncRNA-a' play important roles in chromatin looping through the transcriptional co-activator complex mediator and RNA-processing complex integrator 5,10 , but we observed no requirement for these factors in HIDALGO function ( Supplementary  Fig. 7) . Moreover the susceptibility of neighboring transcriptional effects of ncRNA-a and related lncRNA to RNAi 1, 5, 6, 10, 25 suggests that they may operate in trans 42, 52 , consistent with the intermediate levels of chromatin enrichment compared to cheRNAs. Rather than altering the local chromatin loop structure, other lncRNAs may promote neighboring gene transcription by recruiting methyltransferase complexes to install the transcriptionally activating histone modification H3K4me3 (ref. 1). In the case of the transcriptional and architectural perturbations of HIDALGO by ASOs, the levels of H3K4me3 do not change appreciably at the HBG1 promoter (Fig. 6b) , arguing that similar mechanisms are not functionally relevant in this case. Our data are consonant with the model that promoters of lncRNA may act as enhancer elements, as observed with a recent, elegant report of allele-specific engineering of five lncRNA loci that act in cis to enhance proximal gene expression 13 . However, unlike the HIDALGO-HBG1 gene pair, the functional mechanisms are apparently independent of the RNA molecule itself. We infer cis activity of cheRNA as they are predominantly attached to chromatin through the act of their transcription 14 , and we observed one cheRNA still linked to its site of production (Fig. 2) . Furthermore, perturbing cheRNA transcription often negatively impacts neighboring gene transcription and, in one example, the chromatin architecture coupling an enhancer to the promoter of the neighboring gene is altered when the cheRNA molecule is cleaved (Figs. 3, 5 and 6) . Definitive proof of cis activity of HIDALGO and other cheRNAs requires allele-specific engineering and testing. Further investigation is also needed to precisely define the mechanisms by which cheRNAs promote neighboring gene activation and to explore potential repressive functions as reported for other lncRNAs 4, [52] [53] [54] .
Despite their overall correlation with gene activation, different cheRNAs are unlikely to function by identical mechanisms. One of the cheRNAs we examined, PAINE, does not significantly affect transcription of its nearest neighbor (Fig. 3c,f) , although the present data do rule out a role for PAINE in activating more distal loci or the possibility that PAINE plays no role in transcriptional activation. Nevertheless, four out of five cheRNAs were observed to potentiate transcription of their neighboring gene, and this observation, together with the earlier observation of CRISPRi depletion of PVT1 (ref. 38) , argues for a more general function of cheRNA.
A possible evolutionary origin for cheRNA transcription Class I transposable elements (TEs) carry their own promoters and might provide an evolutionary origin of cheRNAs similar to other lncRNAs 55, 56 . Indeed, 96% of K562 and 98% of H1 CAGE-supported cheRNA overlap with class I TEs. While this enrichment is similar to Gencode lncRNAs bearing CAGE peaks (Supplementary Fig. 8b) , there is only modest correspondence between class I TEs and enhancers annotated by either chromatin signatures (7-38%) or eRNAs (9-15%) (Supplementary Fig.  8b) . Intriguingly, we also identified an ~800-bp region in HIDALGO that corresponds to the insertion of three primate-specific class I TEs (L1PA11, MER41A, and L1P3) during the split between simians and prosimians ( Supplementary Fig. 8a,c) ~35-55 million years ago. It is possible that insertion of these endogenous retroviruses introduced regulatory elements controlling the transition from hemoglobin γ to β, which occurs only during simian primate development 57 . In support of this hypothesis, a reporter construct containing the HIDALGO promoter supported a >80-fold induction of luciferase (Fig. 6c) , whereas a longer promoter fragment containing these TEs displayed a 4.4-fold decrease in luciferase expression (Supplementary Fig. 8d) . Future experiments will address whether these elements contain repressors that contributed to fetal hemoglobin switching during primate evolution, similar to a recently described contribution of TEs to innate immune response 58 .
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
coMPeTING FINANcIAl INTeReSTS
ONLINE METHODS
Cell culture and fractionation. H1 hESCs were grown feeder free on Matrigel (BD Bioscience) in StemPro media (Invitrogen). K562 cells were maintained at ~0.1-1 × 10 6 cells/ml in RPMI 1640 (Gibco), 2 mM Glutamine, 10% FBS, 1% penicillin/streptomycin. 'Plus hemin' cells were treated with freshly prepared 50 µM hemin (Chem IMPEX International) at indicated time points. H1 cells were provided by V. Galat (Northwestern University), and K562 cells were provided by J. Weissman (UCSF). Cell lysis, nuclear fractionation, and RNA isolation were performed as previously described on three independent cultures of 10 7 K562 cells or H1 hESCs 14 . Briefly, purified nuclei were extracted with 0.5 M Urea and 0.5% NP-40 substitute to solubilize loosely bound factors from chromatin and fractionated by centrifugation. RNA from both the chromatin pellet (CP) and soluble nuclear extract (SN) were obtained by Trizol extraction (Life Technologies) and further purified by RNA-Clean and Concentrator columns (Zymo Research) with in-column DNase I digestion as described in the manufacturer's protocol. In vitro transcribed RNA standards (below) were added to purified chromatin pellet and soluble nuclear extract RNA isolates, ribosomal RNA was depleted using Ribo-Zero Gold (Illumina), and stranded cDNA libraries were made using NEBNext Ultra Directional DNA Library Prep Kit for Illumina and sequenced on an Illumina HiSeq2000. K562 and H1 hESC libraries were sequenced by single-end 100-bp reads, and two replicates of hemin-treated K562 cell libraries were sequenced with single-end 50-bp reads.
Calibrated RNA-seq. Spike-in standards were in vitro transcribed with recombinant T7 polymerase 61 and were selected based on lack of homology to human genes and length similarity within the set (777-1,290 nucleotides, Supplementary  Fig. 1a) . RNA was purified with Zymo RNA-Clean and Concentrator columns, serially diluted in a buffer containing 50 mM NaCl, 0.01% NP-40 substitute, 100 ng/µl pUC19, 10 mM Tris-HCl pH 7.5, and 1 mM EDTA, and added to CP and SN RNA before rRNA depletion with Ribo-Zero Gold (Illumina). The four RNA standards were added at 2.7 × 10 6 , 9 × 10 5 , 3 × 10 5 , and 1 × 10 5 copies per K562 library, and 9 × 10 5 , 3 × 10 5 , 1 × 10 5 , and 3 × 10 4 copies per H1 library to create calibration curves. We performed linear regression of the absolute read counts from RNA-seq versus the number of molecules of RNA standard added per cell number equivalent to each library (calculated from the number of cells that each extract was derived from, Supplementary Fig. 1b) . The resulting linear fit equation was used to compute the approximate molecules per cell for cheRNAs based on absolute read counts for each pool (soluble, chromatin pellet) for each biological triplicate (Supplementary Fig. 1c ) and to confirm chromatin versus soluble nuclear extract enrichment. Details of bioinformatics analysis is presented in Supplementary Note 1.
Reverse transcription and RT-qPCR. Reverse transcription of isolated total RNA was performed in 20 µL reactions using 0.5 µg (LNA ASO, HIDALGO knockdown experiments) or 1 µg (all other experiments) total RNA with 100 ng random hexamers (IDT) and 100 U MMLV-HP Reverse Transcriptase (Epicentre) according to manufacturer's instructions. RNA was degraded by 100 mM KOH + 13.3 mM Tris base (final concentration) and incubated at 95 °C for 10 min. Afterwards, the pH was adjusted to ~8.0 using 150 mM HCl, and samples were diluted with 50-200 µL TE buffer (10 mM Tris-HCl + 1 mM EDTA-NaOH, pH 8.0). Real time quantitative PCR (RT-qPCR) was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) and 2-4 µL cDNA per reaction, with 250 nM each primer on a Bio-Rad CFX384 instrument. Three or four technical replicates of each reaction were performed, and all independent replicate targeting and corresponding negative control samples were queried on the same plate.
For CRISPRi in Figure 3 , a total of six unique reference gene candidates (18S rRNA, GAPDH, PGK1, PPIB, TBP, SDHA were evaluated for their relative stability via calculation of the geNorm M value 62 parameter (qbase+ software, Biogazelle). Although these genes exhibit differing absolute stability ranks between the aforementioned groups of samples (i.e. BONIFACIO-targeting samples versus ILYICH-targeting samples), the scale of differences between these candidates across different samples was generally small, and the relative relationships of target genes of interest between samples were generally robust to the reference gene choice. PPIB was ultimately chosen for use across all Figure 3 sample groups on the basis of consistency of its relative expression level (2 ∆Ct ) across negative control experiments. The amplification efficiency and factor of all primers corresponding to Figure 3 were measured using a 5-to 10-point two-fold dilution series of select cDNA samples, where three independent dilution series replicates were performed for PPIB and the amplification factor was calculated as the average across replicates. The amplification factor of each primer set was used as the base for exponentiation of the respective amplicon's mean C t value when calculating "2 ∆Ct ". 18S rRNA was used as the reference gene for all other RT-qPCR displayed.
Fold differences (2 ∆∆Ct ) of targeting samples were calculated relative to the respective negative control samples, with scaling of the mean negative control expression level to 1. Throughout figures displaying relative fold changes, the s.e.m. for targeting samples includes the propagated uncertainty of the mean negative control expression level used for calculating fold differences.
Statistics. For data presented in Figure 1 P values were calculated via the MannWhitney-Wilcoxon test in R. For data presented in Figures 3, 4c, and 5c,d and Supplementary Figure 6c,d , P values were calculated via two-tailed Welch's t test in R. Except for Figure 5c ,d, distributions of raw RT-qPCR data (2 ∆Ct , in all instances averaged from three or four technical qPCR replicates per plate) from all measurements of all independent experiments, before conversion to fold-change values, were compared for significance testing. For Figure 5c ,d, the compared distributions consisted of data following conversion to relative fold-change values. Data shown in Figures 3d,f are calculated from averaging across all independent experiments and two (Fig. 3d,f , sgRNAs 1-4 and '-') or four (Fig. 3f , sgRNAs 5-6 and '-') independent qPCR plates assaying these experiments. Otherwise, data from multiple independent experiments are calculated from averaging of single qPCR plate measurements across the replicate experiments alone (i.e. Figs. 3e and 4c), or across qPCR technical replicates if only single independent experiments were performed (i.e. Fig. 5b,e) . Figure 3d ,e correspond to the n = 3 and n = 6 targeting and negative control experiment counts, respectively, in the stated Figure 3n range. Figure 3f corresponds to the stated n = 4 and n = 7, or n = 1 and n= 2, experiment counts. For Figure 4c and Supplementary Figure 6c -d, t = 0, 2, and 4 h data points correspond to four independent experiments, while t = 8, 12, and 24 h data points correspond to three independent experiments.
Characterization of HIDALGO transcripts. The initial evidence for several HIDALGO transcripts from our CPE sequencing and splice sites detected therein was further supported by 5′ and 3′ RACE using gene-specific primers, CAGE-seq peaks 60 , and RT-qPCR. 5′ RACE was performed using SMARTER 5′/3′ RACE kit (Clontech) following manufacturers protocols. In brief, reverse transcription was performed with random-hexamer primers, and then PCR was performed with Clontech adapters and imaged on a 1% agarose gel stained with ethidum bromide. RACE was performed on either total RNA or chromatin pellet, which yielded similar results. Relative HIDALGO transcript amounts were assessed by RT-qPCR with several primer sets (Supplementary Fig. 4c,e,f) , some of which are isoform specific in that they span spatially disparate exon-exon junctions, and some of which should detect all isoforms. Measurement of relative isoform abundance requires synthesis of direct and indirect evidence: primer sets that detect both isoforms #1 and 2, isoform #3 alone, and the composite of #1-4, respectively. As there are no unique splice sites within HIDALGO isoform #4 that enable selective detection, its levels are inferred by comparison of primer set #1-4 to those that detect #1-2 and #3.
The consensus TATA box is "TATAWAWR" (where W = A/T, R = A/G 63 ), and there is support for binding of this motif by TFIIB of the PIC 10-30 bp upstream of the exact site of initiation with 0 or 1 mismatches 64 . The cryptic TATA box for HIDALGO TSS #4 is "TATAAGTA" which has one purine→purine mismatch relative to consensus, and both 5′-RACE evidence (Supplementary Fig. 4e ) and CAGE-seq (Fig. 4a) suggest that this element is 137 bp upstream of the +1 base. Moreover, the hallmarks of transcriptional initiation 21, 63, 65 are present at this site in ENCODE data sets (H3K4me3, a Pol II peak, DNAse I hypersensitivity, histone acetylation, TF binding sites, Fig. 4a ). cheRNA knockdowns. CRISPRi was performed in K562 or HEK293 cells with dCas9-KRAB integrated in the genome 38, 66 . K562 CRISPRi cells were generously provided by L. Gilbert and J. Weissman (UCSF), and HEK293 CRISPRi cells were generated by Lipofectamine 2000 (Invitrogen) transfection of a modified dCas9-KRAB vector flanked by an FRT site and containing a hygromycin resistance gene, into HEK293 Flp-In (Invitrogen) cells, followed by greater than two weeks of continual hygromycin resistance (100 µg/ml). sgRNAs were designed
